Surrozen, Inc. Common

SRZNNASDAQ • USD
31.61 USD
↘ 0.06 (0.19%)AT CLOSE (03:59 PM EST)
31.53
↘ 0.08 (0.25%)
POST MARKET (AS OF 04:14 PM EST)
Post Market
AS OF 04:14 PM EST
31.53
↘ 0.08 (0.25%)
🔴Market: CLOSED

SRZN is currently priced at $31.61. SRZN shows a split signal: technical indicators suggest "Strong Buy" while underlying fundamentals indicate "Sell". This is driven by a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, exceptional Return on Equity (121.7%), a bullish Golden Cross on the moving averages and bullish moving average alignment. On the valuation front, SRZN trades at elevated multiples relative to its peers, earning a "Richly Valued" assessment.

Technical & fundamental data as of Nov 13, 2026.

Open?$32.34
High?$32.87
Low?$30.40
Prev. Close?$31.67
Volume?106.7K
Avg. Volume?404.4K
VWAP?$31.33
Rel. Volume?0.26x
Bid / Ask
Bid?$20.00 × 100
Ask?$37.50 × 200
Spread?$17.50
Midpoint?$28.75
Valuation & Ratios
Market Cap?602.5M
Shares Out?11.6M
Float?12.6M
Float %?70.7%
P/E Ratio?N/A
P/B Ratio?-1.80
EPS?-$21.42
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Surrozen Inc is a clinical-stage biotechnology company committed to discovering and developing drug candidates to selectively modulate the Wnt pathway, a critical mediator of tissue repair, in a broad range of organs and tissues. Its product candidate includes SZN-8141(for wet AMD, DME), SZN-413( For retinopathies) and SZN-8143 (for wet AMD, DME, UME).
Employees
44
Market Cap
554.1M
Industry
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Listed
2021-08-12
Address
171 OYSTER POINT BLVD
SOUTH SAN FRANCISCO, CA 94080
Phone: 650-475-2820
Technical OutlookStrong Buy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+3/3)
Medium-Term (Wave)?▲ Bullish(+2/3)
Short-Term (Ripple)?– Neutral(0/3)
MA Alignment?Golden Alignment
Full Technical Analysis →
Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?
3
Z-Score?
0
Momentum?
50
Short Sent.?
36
Piotroski F-Score?0/9Weak
Altman Z-Score?-9.08Distress
Confidence?59%Low
Full Fundamental Analysis →
Short InterestSqueeze Risk
Short % of Float?25.71%Squeeze Risk
Short Interest?3.2M
Days to Cover?8.5
Free Float12.6M
Avg Daily Volume380.0K
Settlement Date2026-10-30
Financial Health
Current Ratio?7.56Strong
Quick Ratio?7.56Strong
Cash Ratio?7.37Strong
Debt/Equity?-0.00Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score
67/100
P/E?
N/A▾
P/B?
S&P
97
-1.80CHEAP▾
P/S?
Peers
100
S&P
3
57.23HIGH▾
P/FCF?
N/A▾
EV/EBITDA?
S&P
97
-9.9CHEAP▾
EV/Sales?
Peers
100
S&P
3
47.70HIGH▾
Returns & Efficiency
ROE?
Peers
50
S&P
97
121.7%STRONG▾
ROA?
S&P
3
-374.5%WEAK▾
Cash Flow & Enterprise
FCF?$-30775000
Enterprise Value?$502.2M
Fundamentals ratios updated end of day